The Prospective Payment System-Exempt Cancer Hospital Quality Reporting Outcomes dataset evaluated the percentage of patients who received outpatient chemotherapy treatment at exempt cancer hospitals for all cancer types except leukemia who were admitted to the hospital within 30 days after treatment.
Here are the 11 hospitals ranked by hospital admission rates:
1. Fred Hutchinson Cancer Institute (Seattle): 10.3 percent
2. USC Kenneth Norris Jr. Cancer Hospital (Lost Angeles): 11 percent
3. H. Lee Moffitt Cancer Center & Research Institute (Tampa, Fla.): 12 percent
4. University of Miami Health System-Sylvester Comprehensive Cancer Center: 12.2 percent
4. Fox Chase Cancer Center (Philadelphia): 12.2 percent
6. James Cancer Hospital & Solove Research Institute (Columbus, Ohio): 12.3 percent
7. Roswell Park Cancer Institute (Buffalo, N.Y.): 13.2 percent
8. City of Hope Helford Clinical Research Hospital (Durante, Calif.): 13.4 percent
9. Memorial Sloan Kettering Cancer Center (New York City): 13.8 percent
10. University of Texas M. D. Anderson Cancer Center (Houston): 13.9 percent
11. Dana-Farber Cancer Institute (Boston): 14.4 percent
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
